Search research articles
Contact Us
Filters
Showing results (591-600 of 717) with videos related to
Page
of 72
Sort By:
Blood Advances
|
February 9, 2021
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
Andrei Shustov, Maria Elena Cabrera, Monica Civallero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2024
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)
Daniel M Geynisman, Philip H Abbosh, Eric Ross, et al.
Blood Advances
|
January 25, 2024
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
Kurt S Bantilan, Alexandra N Smith, Matthew J Maurer, et al.
Haematologica
|
September 5, 2024
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience
Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, et al.
Blood
|
February 17, 2019
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
Sven Borchmann, Erel Joffe, Craig H Moskowitz, et al.
Hematological Oncology
|
September 9, 2022
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project
Carlos Chiattone, Monica Civallero, Thais Fischer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2019
Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials
Christopher L Hallemeier, Peixin Zhang, Thomas M Pisansky, et al.
Blood Advances
|
April 26, 2022
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2
Kerry J Savage, Steven M Horwitz, Ranjana Advani, et al.
European Urology
|
May 13, 2023
Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial
Oliver Sartor, Theodore G Karrison, Howard M Sandler, et al.
Haematologica
|
June 11, 2026
Outcomes in early stage peripheral T-cell lymphoma by stage, histology, and treatment patterns
Robert Stuver, Zachary R Moore, Stefan K Barta, et al.
Page
of 72
Search research articles
Search
Showing results (591-600 of 717) with videos related to
Sort By:
Page
of 72
Blood Advances
|
February 9, 2021
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
Andrei Shustov, Maria Elena Cabrera, Monica Civallero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2024
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)
Daniel M Geynisman, Philip H Abbosh, Eric Ross, et al.
Blood Advances
|
January 25, 2024
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
Kurt S Bantilan, Alexandra N Smith, Matthew J Maurer, et al.
Haematologica
|
September 5, 2024
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience
Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, et al.
Blood
|
February 17, 2019
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
Sven Borchmann, Erel Joffe, Craig H Moskowitz, et al.
Hematological Oncology
|
September 9, 2022
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project
Carlos Chiattone, Monica Civallero, Thais Fischer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2019
Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials
Christopher L Hallemeier, Peixin Zhang, Thomas M Pisansky, et al.
Blood Advances
|
April 26, 2022
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2
Kerry J Savage, Steven M Horwitz, Ranjana Advani, et al.
European Urology
|
May 13, 2023
Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial
Oliver Sartor, Theodore G Karrison, Howard M Sandler, et al.
Haematologica
|
June 11, 2026
Outcomes in early stage peripheral T-cell lymphoma by stage, histology, and treatment patterns
Robert Stuver, Zachary R Moore, Stefan K Barta, et al.
Page
of 72